In this study, adjuvant radiotherapy was recommended for patients with a high likelihood of recurrence, such as a high MIB1 index, whereas salvage therapy was selected as a treatment strategy for those who experience tumor progression. The gene discussed is MIB1; the disease is neoplasm.